Tzu Chi Medical Journal, published by Wolters Kluwer Medknow Publications, is a prominent open-access journal that has been serving the medical community since its inception in 1997. With an ISSN of 1016-3190 and an E-ISSN of 2223-8956, this journal is dedicated to disseminating valuable research across various domains of medicine, achieving a prestigious Q3 ranking in the Medicine (miscellaneous) category for 2023. Operating under an open-access model since 2017, it ensures that research is freely accessible to a global audience, fostering collaboration and innovation in healthcare. Tzu Chi Medical Journal is recognized for its quality contributions, ranked #152 out of 636 in the general medicine category on Scopus, placing it in the top 25% of journals in this field. Based in Mumbai, India, it serves as an essential platform for researchers, healthcare professionals, and students aiming to share and engage with groundbreaking work in medicine, thus driving the field forward.

Advances in Traditional Medicine, published by SPRINGER, stands at the forefront of the Complementary and Alternative Medicine field, dedicated to exploring the intricate landscapes of traditional medical practices worldwide. With an impressive 2023 Q2 ranking and a Scopus rank of #30/105, this journal is committed to advancing scholarly discourse and innovation in the study and practice of traditional medicine, making it an essential resource for researchers, practitioners, and students alike. As an Open Access journal, it ensures wide accessibility to cutting-edge research and developments from 2020 to 2024, fostering collaboration and knowledge exchange in the global medical community. Based in Singapore, with operations linked to VAN GODEWIJCKSTRAAT 30, 3311 GZ Dordrecht, Netherlands, this journal not only enhances its reach but also enriches the academic landscape with its significant contributions to understanding the role of traditional medicine in contemporary healthcare.

Natural Product Communications is an esteemed open-access journal published by SAGE Publications Inc, dedicated to the exploration and dissemination of knowledge concerning natural products in diverse fields, including Complementary and Alternative Medicine, Drug Discovery, and Pharmacology. Since its inception in 2006 and continuing through its converged years until 2024, the journal has gained recognition with a robust focus on plant science and the medicinal properties of natural products. With a commendable impact factor reflected in its category quartiles (Q3 across key domains), Natural Product Communications serves as a vital resource for researchers and professionals who aim to further the understanding of the therapeutic potential of natural compounds. As an open-access journal since 2020, it ensures wide accessibility to its published research, thereby facilitating collaboration and innovation within the scientific community. This commitment to excellence makes Natural Product Communications a crucial platform for advancing research in the holistic and pharmacological sciences.

The Journal of Ethnopharmacology, published by Elsevier Ireland Ltd, is a pivotal resource in the fields of Drug Discovery and Pharmacology, recognized as a Q1 journal in both categories as of 2023. With a rich history since its inception in 1979, this peer-reviewed journal provides a platform for rigorous research and innovative findings related to traditional medicinal practices and the therapeutic potential of natural products. The journal is ISSN 0378-8741 and E-ISSN 1872-7573, and it plays a vital role in advancing knowledge through its high-quality publications, which rank impressively at #35 out of 313 in Pharmacology and #19 out of 157 in Drug Discovery according to Scopus metrics. Although not open access, the journal aims to cater to a diverse audience of researchers, professionals, and students dedicated to exploring the intersection of ethnopharmacology and modern scientific inquiry. Its comprehensive scope encapsulates a multitude of studies spanning the globe, fostering a deeper understanding of how traditional practices can inform contemporary health solutions.

JOURNAL OF HERBS SPICES AND MEDICINAL PLANTS, published by Taylor & Francis Ltd, serves as a pivotal platform for researchers and professionals in the fields of Complementary and Alternative Medicine and Pharmacology. With an ISSN of 1049-6475 and E-ISSN of 1540-3580, this journal is dedicated to advancing the understanding of the therapeutic potential of herbs, spices, and various medicinal plants, and showcases high-quality, peer-reviewed research from 1992 to 2024. As of 2023, it holds a respectable Q3 ranking in both relevant categories, exhibiting its growing influence within the academic community. The journal is not open access, yet it remains a vital resource for those exploring the diverse applications and efficacy of plant-based therapies. Researchers and students alike will benefit from the journal’s commitment to disseminating innovative findings that can enhance the quality of life through natural remedies, thereby contributing significantly to the global discourse on herbal medicine.

Journal of Pharmacy & Pharmacognosy Research, published by JOURNAL PHARMACY & PHARMACOGNOSY RESEARCH-JPPRES, is a prominent open-access journal established in 2013, headquartered in Antofagasta, Chile. With a focus on the fields of Complementary and Alternative Medicine, Drug Discovery, Pharmaceutical Science, Pharmacology, and Pharmacy, this journal is recognized for its commitment to advancing research and disseminating knowledge within these important areas. With a current impact factor that reflects its academic rigor and relevance, the journal has achieved substantial recognition, evident by its Q2 and Q3 quartile rankings in multiple categories, indicating its growing influence on the scientific community. The Scopus rankings further highlight its standing in pharmacy and pharmacological disciplines, providing a valuable platform for researchers, professionals, and students to share their findings and insights. With its open access model, the journal ensures that high-quality research is available to a global audience, paving the way for collaborative advancements in pharmaceutical sciences.

COMPLEMENTARY THERAPIES IN MEDICINE, published by Churchill Livingstone, is a premier Open Access journal that has been at the forefront of advancing knowledge in the fields of complementary and alternative medicine since its inception in 1993. With a strong impact in health professions, nursing, and complementary therapies, this journal holds a prestigious spot in the top quartile rankings for 2023, including Q1 classifications in Advanced and Specialized Nursing, Complementary and Alternative Medicine, and Complementary and Manual Therapy. Its Scopus rankings further attest to its significance, being ranked #1 in Complementary and Manual Therapy with an impressive 97th percentile. The journal's commitment to accessibility is underscored by its Open Access policy since 2021, ensuring that researchers, professionals, and students have unrestricted access to high-quality research that informs practice and policy. With a focus on evidence-based approaches, the journal serves as an essential resource for those looking to integrate complementary therapies into holistic healthcare strategies.

PHARMACEUTICAL BIOLOGY, published by Taylor & Francis Ltd, is a prominent open-access journal that has been a cornerstone of research in the life sciences since its convergence in 1961. With a strong focus on Complementary and Alternative Medicine, Pharmaceutical Science, and Drug Discovery, this journal is dedicated to disseminating groundbreaking research that intersects pharmaceuticals and biology. Acknowledged for its rigorous peer-review process, it holds a prestigious Q1 ranking in Pharmaceutical Science and exemplifies the commitment to quality and impact in the field, boasting an impressive Scopus rank of #14/105 in the complementary and alternative medicine category. Researchers keen on advancing their knowledge in these fields will find PHARMACEUTICAL BIOLOGY an invaluable resource, offering accessibility since its shift to open access in 2017. This journal presents a platform for innovative studies that contribute to the evolving understanding of pharmaceutical applications and biological interactions, serving as an essential hub for researchers, professionals, and students alike.

PLANTA MEDICA is a premier journal dedicated to advancing the field of medicinal plant research, published by Georg Thieme Verlag KG in Germany. With an ISSN of 0032-0943 and an E-ISSN of 1439-0221, this journal has been a cornerstone of scholarly communication since its inception in 1961. Recognized for its rigorous peer-review process, PLANTA MEDICA holds a notable reputation in the academic landscape, featuring a 2023 Q2 ranking in categories such as Analytical Chemistry and Pharmaceutical Science, along with respectable Q3 rankings in Drug Discovery and Molecular Medicine. The journal focuses on the synthesis, pharmacological, and biochemical assessment of phytochemicals, making it an essential resource for researchers, professionals, and students alike who are engaged in the exploration of complementary and alternative medicine. Although it does not offer open access options, its content is instrumental in identifying new therapeutic agents derived from plants, thereby underscoring its importance in drug discovery and holistic health research.

Advances in Integrative Medicine is a prestigious academic journal published by Elsevier, dedicated to the field of Complementary and Alternative Medicine. With an ISSN of 2212-9588 and an E-ISSN of 2212-9596, this journal has gained recognition for its high-quality research contributions, achieving a commendable Q2 ranking in the 2023 category of Complementary and Alternative Medicine according to Scopus, placing it at #39/105 in its field with a 63rd percentile ranking. Since its inception in 2014, the journal has been committed to advancing the understanding of integrative medicine practices through rigorous peer-reviewed research, systematic reviews, and innovative methodologies. Although it does not offer open access options, it remains a vital resource for researchers, professionals, and students interested in the latest evidence-based approaches within this dynamic and evolving area of healthcare. Based in Australia, with operations located at RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, Advances in Integrative Medicine continues to serve as a leading platform for scholarly discourse, fostering advancements that can enhance patient care and therapeutic outcomes.